Adderall

NarcX+ First to Meet DEA Standards for Destroying Illicit Fentanyl and Rendering It Non-Retrievable

Retrieved on: 
Tuesday, January 16, 2024

NarcX+ has successfully completed the first independent validation, by a 3rd party criminal laboratory, of its kind by testing its effectiveness against illicit fentanyl tablets and powders.

Key Points: 
  • NarcX+ has successfully completed the first independent validation, by a 3rd party criminal laboratory, of its kind by testing its effectiveness against illicit fentanyl tablets and powders.
  • The environmentally safe solution, NarcX+, has been analytically tested using LCMS technology, and proven that after a short amount of time the illicit fentanyl drug is non-detectable and non-retrievable meeting all DEA standards.
  • The Center for Forensic Science Research & Education (CFSRE), a forensic toxicology and chemistry laboratory, conducted a series of analytical tests by adding illicit fentanyl to NarcX+.
  • The tests conducted validate that at 5 minutes illicit fentanyl tablets are completely destroyed and non-retrievable.

The Women's Sports Foundation Welcomes New President and Six Board of Trustees Members, as it Celebrates its 50th Anniversary

Retrieved on: 
Thursday, January 11, 2024

NEW YORK, Jan. 11, 2024 /PRNewswire/ -- As of January 1, the Women's Sports Foundation (WSF) is pleased to welcome Paralympian and world record holder in Track & Field, Scout Bassett, as its new president, and also welcomes six members to its Board of Trustees. The new trustees include: Andrea Brimmer, Ally Financial's chief marketing and public relations officer who spearheaded the creation of the Ally brand; Arielle Chambers, mixed-media journalist and founder of Warner Bros. Discovery's HighlightHer who uses her platforms to amplify the voices of women athletes; Ashlyn Harris, two-time Women's World Cup champion who currently serves as global creative advisor for Gotham FC; Katy Knox, former NCAA athlete and president of Bank of America Private Bank who has more than 35 years of financial services experience; Kathleen Kunkler, recently retired Morgan Stanley executive who served as senior vice president, Global Sports and Entertainment director for more than 34 years; and Nicole Jeter West, co-founder of Vanguard Maven Group who has more than 20 years of experience in the sports and entertainment industry. This innovative group of cross-sector professionals join WSF in time for the Foundation's 50th anniversary in 2024 – a year that will honor WSF's role as one of the first organizations to recognize that equality in sport leads to equality in life.

Key Points: 
  • "Scout is a longtime, valued member of the WSF family, and we are thrilled she is taking over as president," said WSF CEO Danette Leighton.
  • "We are also delighted to welcome Andrea, Arielle, Ashlyn, Katy, Kathleen and Nicole to our board.
  • Together, our WSF family will honor our legacy while deepening our impact as we mark this special, 50th anniversary year.
  • For a complete list of the Women's Sports Foundation's Board of Trustees, please click here .

A brief history of drug-fuelled combatants

Retrieved on: 
Tuesday, January 2, 2024

I don’t know whether he thought that it might reduce pain or improve performance, but the idea of taking drugs before “going into battle” goes back to the beginning of recorded history.

Key Points: 
  • I don’t know whether he thought that it might reduce pain or improve performance, but the idea of taking drugs before “going into battle” goes back to the beginning of recorded history.
  • Indeed, we find frequent mentions of mead drinking by the warriors in Edinburgh in the seventh-century epic poem The Goddodin.
  • These ancient warriors probably used alcohol to reduce anxiety and blunt the horrors they would face on the battlefield.
  • Pervitin (methamphetamine) was given almost freely to all arms of the German war machine.
  • The frontline Nazis called them Panzerschokolade (tank chocolate), due to the feelings of incredible strength and invincibility that the pills gave them.

Behavioural effects


The types of drugs taken by warriors can be lumped into three broad categories: depressants, hallucinogens and stimulants. Alcohol is a depressant that calms the nerves by reducing brain activity. Psychedelic mushrooms such as Amanita muscaria contain a variety of psychoactive substances. Hyoscyamus niger also has a variety of active compounds that cause hallucinations and, importantly, aggressive and combative behaviour.

  • The word “groggy” meaning dazed and unsteady came from British navy sailors exhibiting this behaviour after their daily ration of rum and water (grog).
  • The stimulants, but especially methamphetamine, would also lead to significant weight loss even after only a few days of use.
  • Long-term use, as we saw with the Nazis, would probably lead to emaciated soldiers.

Smart drugs

  • We have seen that soldiers take drugs before battles to calm nerves, deal with the horrors, reduce pain, tolerate lack of food and sleep and improve alertness.
  • The stimulants include drugs such as amphetamine salt mixtures, methylphenidate and modafinil, while nootropics include piracetam, caffeine, cobalamin (vitamin B12), guarana, pyridoxine (vitamin B6) and vinpocetine.
  • The integration of humans, technology and machines is thought to be the future of warfare and drugs that facilitate this are undoubtedly being researched by the military.

Post-traumatic stress disorder

  • There is a long history of soldiers taking alcohol and other drugs to deal with the horrors of what they have seen, or the disappointment of life after leaving the army.
  • These veterans are taking MDMA and psilocybin on doctors’ orders as part of their treatment for PTSD.
  • Ketamine is useful for treating depression and LSD is also being tested for various psychiatric disorders.


Colin Davidson has previously received funding from the US National Institute on Drug Abuse (NIDA). He is a consultant with the Defence Science and Technology Laboratory (UK).

Delix Therapeutics Awarded National Institutes of Health Grant to Advance Vital Research of Novel Neuroplastogen for Substance Use Disorders

Retrieved on: 
Wednesday, December 13, 2023

DLX-007 is a novel, first-in-class, neuroplastogen being evaluated in a range of substance use disorders (SUDs), including opioid and stimulant use.

Key Points: 
  • DLX-007 is a novel, first-in-class, neuroplastogen being evaluated in a range of substance use disorders (SUDs), including opioid and stimulant use.
  • "With nearly 110,000 people dying from drug overdoses in America last year, substance use disorders remain a critical public health issue with limited treatment options.
  • Preliminary data are being generated for its potential efficacy in treating substance use disorders with cocaine, amphetamines, and multiple substances.
  • Delix is rapidly advancing its library of thousands of novel compounds into scalable, orally-bioavailable, take-home therapies.

Fentanyl.org Launches Platform Providing Real Time Help - Get Reliable Information About Fentanyl & Synthetic Opioids Comprehensive Directory of Treatment & Opiate Detox Options

Retrieved on: 
Wednesday, November 8, 2023

COMMACK, N.Y., Nov. 8, 2023 /PRNewswire/ -- Fentanyl kills more people in the USA than have died in wars. It is so deadly that even inhaling it can cause death First responders have died from coming into contact with it, as it is easily absorbed through the skin. Fentanyl comes into the USA from the land, sea and air borders. The nations youth are dying in record numbers from Fentanyl Laced counterfeit street drugs.

Key Points: 
  • Over 300 Americans die every day from overdoses related to synthetic opioids like fentanyl.
  • Fentanyl is a synthetic opioid that is up to 50X stronger than heroin and 100X stronger than morphine.
  • Fentanyl is commonly used to create counterfeit drugs sold on the street as OxyContin, Xanax, Adderall, and other pills.
  • In 2022, the DEA seized more than 58.3 million pills containing fentanyl and more than 13,000 pounds of fentanyl powder.

ADHD drug shortages are affecting patients in the UK – here's why they're happening

Retrieved on: 
Tuesday, November 7, 2023

Millions of people in the UK who take drugs for attention deficit hyperactivity disorder (ADHD) are facing difficulties getting their prescriptions filled due to shortages.

Key Points: 
  • Millions of people in the UK who take drugs for attention deficit hyperactivity disorder (ADHD) are facing difficulties getting their prescriptions filled due to shortages.
  • These shortages are currently affecting four of the five types of medicine licensed in the UK to treat ADHD.

What’s causing these shortages?

  • Not only that, but a growing number of adults are now being diagnosed with ADHD – meaning that even more people are seeking access to ADHD drugs.
  • For example, between April and June 2023 about 202,000 new people in England received a prescription for these drugs.
  • Multiple factors have been linked to this shortage – including a manufacturing delays, increased demand, restrictions on what drugs pharmacists can supply and quota issues.
  • In the US, the quotas may be too low, manufacturing may not be optimised, or the right people may not be receiving the products, causing shortages.
  • There are now reports that people are also having difficulty filling other ADHD medications, such as Concerta and Focalin.

Managing shortages

  • They can help them concentrate better, be less impulsive, feel calmer and learn and practise new skills.
  • Some patients report rationing their prescriptions to make them last longer or have taken to stockpiling them.
  • Patients who have been affected will have been notified by their normal pharmacy of any supply issues.
  • Changing medications or prescribed dosages can sometimes be a strategy to manage shortages so that patients can continue treatment.
  • It’s also unclear if the shortages will be resolved by the end of 2023 as predicted.


The authors do not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.

Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen

Retrieved on: 
Friday, October 27, 2023

Complemented by the detection of cocaine, opioids, PCP, and amphetamines, the advanced panel is a leap forward in drug screening technology.

Key Points: 
  • Complemented by the detection of cocaine, opioids, PCP, and amphetamines, the advanced panel is a leap forward in drug screening technology.
  • Traditional 5-panel drug tests, rooted in a four-decade-old paradigm, have failed to evolve in today’s drug market and are unable to detect the rising drug, fentanyl.
  • The Advanced 5-Panel Drug Screen epitomizes this legacy, offering clients a cost-effective choice to adapt their testing protocols in sync with evolving priorities and employment policies.
  • The Advanced 5-Panel Drug Screen is crafted to focus exclusively on these critical threats, ensuring the highest level of security for organizations.

How do stimulants actually work to reduce ADHD symptoms?

Retrieved on: 
Friday, October 27, 2023

Stimulants are first-line drugs for children and adults diagnosed with attention-deficit hyperactivity disorder (ADHD). But how do they actually work?First, let’s look at the brainMedical imaging indicates people with ADHD may have slight differences in their brain’s structure, the way their brain regions work together to perform tasks, and how their brain’s chemical messengers, called neurotransmitters, pass on information.

Key Points: 


Stimulants are first-line drugs for children and adults diagnosed with attention-deficit hyperactivity disorder (ADHD). But how do they actually work?

First, let’s look at the brain

  • Medical imaging indicates people with ADHD may have slight differences in their brain’s structure, the way their brain regions work together to perform tasks, and how their brain’s chemical messengers, called neurotransmitters, pass on information.
  • These brain differences are associated with the symptoms of ADHD, including inattention, impulse control and problems with memory.

What stimulants are prescribed in Australia?

  • The three main stimulants prescribed for ADHD in Australia are dexamfetamine, methylphenidate (sold under the brand names Ritalin and Concerta) and lisdexamfetamine (sold as Vyvanse).
  • Dexamfetamine and methylphenidate have been around since the 1930s and 1940s respectively.

So how do they work for ADHD?

  • Stimulants increase the amount of dopamine and noradrenaline in the tiny gaps between neurons, known as synapses.
  • They do this by predominantly blocking a transporter that then prevents their re-uptake back into the neuron that released them.
  • Amphetamines also increase the amount of dopamine the neuron releases into the synapse (the tiny gaps between neurons).

What effect do they have on ADHD symptoms?


We still don’t fully understand the underlying brain mechanisms that change behaviour in people with ADHD. But research shows stimulants that modulate noradrenaline and dopamine can improve brain processes such as:
They can also improve general behaviour, such as self-control, not talking over the top of others, and concentration. These behaviours are important for social interactions. Stimulants reduce ADHD symptoms in about 70% to 80% of children and adults who take them. Some people will notice their symptoms improve right away. Other times, these improvements will be more noticeable to parents, carers, teachers, colleagues and partners.

Not everyone gets the same dose


The optimal stimulant dose varies between individuals, with multiple dosage options available. This enables a “start low, go slow” approach, where the stimulant can be gradually increased to the most effective dose for the individual.

  • Dexamfetamine and methylphenidate are available in immediate-release preparations.
  • As these have short half-lives (meaning they act quickly and wear off rapidly), they are often taken multiple times a day – usually in the morning, lunch and afternoon.
  • Methylphenidate is also available in long-acting tablets (Concerta) and capsules (Ritalin LA).

What are the side effects?


The most common side effects are sleep problems and decreased appetite. A recent study showed children and young people taking methylphenidate for ADHD were around 2.6 times more likely to have sleep problems and 15 times more likely to have a decreased appetite than those not taking methylphenidate. Headache and abdominal pain are also relatively common.

Can someone without ADHD take a stimulant to improve productivity?

  • As stimulants increase dopamine, they can cause euphoria and a heightened sense of wellbeing.
  • A common myth about stimulant medicines is they can improve the concentration and productivity of people without ADHD.
  • At each of the sessions, participants were given either a placebo or a stimulant before completing the task.
  • Read more:
    ADHD medications have doubled in the last decade – but other treatments can help too


Mary Bushell does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

More adults than ever have been seeking ADHD medications – an ADHD expert explains what could be driving the trend

Retrieved on: 
Friday, August 4, 2023

I started receiving a wave of advertisements beckoning me to get online help for ADHD, or attention-deficit/hyperactivity disorder.

Key Points: 
  • I started receiving a wave of advertisements beckoning me to get online help for ADHD, or attention-deficit/hyperactivity disorder.
  • The reason the term ADHD litters my digital life is because I am a clinical psychologist who exclusively treats patients with ADHD.
  • The brand name Adderall and its generic counterparts have become one of the most common medication treatments for ADHD.
  • Over the next several months, additional ADHD medications joined Adderall on the list of prescription drugs in short supply.
  • The CDC’s findings, along with the stimulant shortage, raise some interesting – and still unanswered – questions about what factors are driving these trends.

The challenge of diagnosing adult ADHD

    • Despite the growth in awareness of ADHD over the past couple of decades, many people with ADHD, particularly women and people of color, go undiagnosed in childhood.
    • Diagnosing ADHD in either kids or adults first involves establishing that ADHD-like traits, which exist on a continuum and can fluctuate, are severe and chronic enough to prevent a person from living a normal, healthy life.
    • Diagnostic challenges can also arise for psychiatrists and other health care practitioners because ADHD shares features with many other conditions.

Stress of the COVID-19 pandemic

    • In 2021, the U.S. was still deep in the acute phase of the COVID-19 pandemic.
    • Many families were losing loved ones, and there was a huge sense of uncertainty over when normal life would return.
    • The demands of the pandemic took a toll on everyone, but research shows that women may have been disproportionately affected.
    • In addition, without access to in-person recreational spaces, the pandemic increasingly drove many people to spending more time on digital media.

What ADHD care looked like in 2021

    • People who were newly seeking help for ADHD found faster appointments with their primary care providers, who may or may not be comfortable diagnosing and treating adult ADHD.
    • Around that time, online ADHD care startups began to pop up, reaching prospective consumers with appealing digital ads like the ones I received.
    • Although they were controversial in the medical community, these models may also have reduced barriers to ADHD care for many people.

The verdict is still out

    • If the trends stabilize, it may mean that patients who have been unable to access care may finally be getting the help they need.
    • If ADHD prescribing returns to pre-pandemic levels, we may learn that a perfect storm of COVID-19-related factors caused a momentary blip in people seeking ADHD treatment.

Prodrugs: pills your body converts into an illicit drug can evade detection, but we don't know how big the problem is

Retrieved on: 
Monday, July 24, 2023

Prodrugs are substances that can only cause an effect after being broken down by enzymes in the digestive system or other chemical reactions in the body.

Key Points: 
  • Prodrugs are substances that can only cause an effect after being broken down by enzymes in the digestive system or other chemical reactions in the body.
  • Most illicit drugs work by interacting with specific brain cell receptors, stimulating or blocking the release of chemicals called neurotransmitters.
  • They last for a short time before being transformed into inactive or less active chemicals, which are then eliminated from the body, usually in urine.
  • For prodrugs, however, a small part of the molecule needs to be removed or substituted before it can act on those receptors.

Hard to detect

    • A major problem with prodrugs is they are difficult to detect.
    • Police forces need reference samples to compare the drug with, or advanced equipment to discover its molecular structure.
    • It also explains why many have only appeared in police reports in the past decade.
    • For biological samples (such as blood, urine or saliva), there is another difficulty.